Liveware

Liveware

Home
Notes
Archive
About
Actions per minute
What StarCraft 2 taught me about B2B SaaS
May 23, 2025 • Alex Telford
Some notes on the aesthetic of progress
Progress art as harmony between technology and nature
Mar 17, 2024 • Alex Telford
But does surgery really work well without the FDA?
Or maybe the FDA is good actually
Feb 10, 2024 • Alex Telford
The burden of prestige
Reflections on “The Trajectory of Discovery”, by Mark Khurana
Dec 19, 2023 • Alex Telford
Depression as a local minima
Do antidepressants work via simulated annealing?
Dec 6, 2023 • Alex Telford
Latent optima
In which I argue that information about optimality is encoded into datasets by selection processes
Nov 17, 2023 • Alex Telford
Super Mario, scientist
What video game speedrunning can teach us about automating scientific discovery
Nov 7, 2023 • Alex Telford
Schadenfreude in drug development
Optimism as a moral duty
Oct 26, 2023 • Alex Telford
Should the UK embrace its role as an exporter of talent and ideas?
A proposal for a UK 'sovereign innovation fund'
Oct 19, 2023 • Alex Telford
Concepts of health and disease as a barrier to progress
This essay was the runner-up in the Homeworld Ideas writing contest.
Oct 16, 2023 • Alex Telford
Liveware
Liveware
I write about the science and business of living things: the biotech industry, drug discovery, biology, medicine, consciousness, intelligence (artificial and natural), and natural philosophy. Mostly I write about the biotech industry.
Recommendations
Asymmetric Learning - Pharmaceutical Innovation
Asymmetric Learning - Pharmaceutical Innovation
Mike Rea, SAI/ IDEA Pharma
The Roots of Progress
The Roots of Progress
Jason Crawford
Asimov Press
Asimov Press
Asimov Press

Liveware

AboutArchiveRecommendationsSitemap
© 2026 Alex Telford · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture